CARTER, H. BALLENTINE : rechercher sur Z-Library

Loeb, Stacy, Carter, H. Ballentine, Berndt, Sonja I., Ricker, Winnie, Schaeffer, Edward M.

Année:

2009

Langue:

english

Fichier:

PDF, 145 KB

english, 2009

Complications After Prostate Biopsy: Data From SEER-Medicare

Journal:

Greene, Kirsten L., Albertsen, Peter C., Babaian, Richard J., Carter, H. Ballentine, Gann, Peter H., Han, Misop, Kuban, Deborah Ann, Sartor, A. Oliver, Stanford, Janet L., Zietman, Anthony, Carroll, P

Année:

2011

Langue:

english

Fichier:

PDF, 337 KB

english, 2011

Prostate Specific Antigen Best Practice Statement: 2009 Update

Journal:

BROOKS, JAMES D., METTER, E.JEFFREY, CHAN, DANIEL W., SOKOLL, LORI J., LANDIS, PATRICIA, NELSON, WILLIAM G., MULLER, DENIS, ANDRES, REUBIN, CARTER, H.BALLENTINE

Année:

2013

Langue:

english

Fichier:

PDF, 1.48 MB

english, 2013

PLASMA SELENIUM LEVEL BEFORE DIAGNOSIS AND THE RISK OF PROSTATE CANCER DEVELOPMENT

Journal:

Loeb, Stacy, Kettermann, Anna, Carter, H. Ballentine, Ferrucci, Luigi, Metter, E. Jeffrey, Walsh, Patrick C.

Année:

2001

Langue:

english

Fichier:

PDF, 72 KB

english, 2001

Prostate Volume Changes Over Time: Results From the Baltimore Longitudinal Study of Aging

Journal:

Berger, Zackary D., Yeh, Jonathan C., Carter, H. Ballentine, Pollack, Craig Evan

Année:

2009

Langue:

english

Fichier:

PDF, 172 KB

english, 2009

Characteristics and Experiences of Patients with Localized Prostate Cancer Who Left an Active Surveillance Program

Journal:

The Patient: Patient-Centered Outcomes Research

Année:

2014

Langue:

english

Fichier:

PDF, 268 KB

english, 2014

Magnetic Resonance-Guided Prostate Biopsy

Dianat, S. Saeid, Carter, H. Ballentine, Macura, Katarzyna J.

Journal:

Magnetic Resonance Imaging Clinics of North America

Année:

2015

Langue:

english

Fichier:

PDF, 1.69 MB

english, 2015

The Use of Prostate Specific Antigen, Clinical Stage and Gleason Score to Predict Pathological Stage in Men with Localized Prostate Cancer

Partin, Alan W., Yoo, John, Carter, H. Ballentine, Pearson, Jay D., Chan, Daniel W., Epstein, Jonathan I., Walsh, Patrick C.

Journal:

Tosoian, Jeffrey J., Carter, H. Ballentine

Année:

1993

Langue:

english

Fichier:

PDF, 187 KB

english, 1993

Risk Stratification in Active Surveillance: A Dynamic, Ever-Evolving Practice

Journal:

Année:

2018

Langue:

english

Fichier:

PDF, 121 KB

english, 2018

MP40-10 EXTENDED VALIDATION RESULTS FROM A PROSPECTIVE ADAPTIVE UTILITY TRIAL CONFIRM PERFORMANCE OF A NOVEL URINE EXOSOME GENE EXPRESSION ASSAY TO PREDICT HIGH-GRADE PROSTATE CANCER AT INITIAL BIOPSY

McKiernan, James, Donovan, Michael, Margolis, Eric, Partin, Alan, Carter, H. Ballentine, Brown, Gordon, Torkler, Phillipp, Noerholm, Mikkel, Bentis, Chris, Skog, Johan, Shore, Neal, Thompson, Ian, And

Journal:

Lange, Jane M., Gulati, Roman, Leonardson, Amy S., Lin, Daniel W., Newcomb, Lisa F., Trock, Bruce J., Carter, H. Ballentine, Carroll, Peter R., Cooperberg, Matthew R., Cowan, Janet E., Klotz, Lawrence

Année:

2018

Langue:

english

Fichier:

PDF, 39 KB

english, 2018

Estimating and comparing cancer progression risks under varying surveillance protocols

Journal:

The Annals of Applied Statistics

Année:

2018

Langue:

english

Fichier:

PDF, 770 KB

english, 2018

Evaluation of apparent diffusion coefficient as a predictor of grade reclassification in men on active surveillance for prostate cancer

Huang, Mitchell M., Macura, Katarzyna J., Landis, Patricia, Epstein, Jonathan I., Gawande, Rakhee, Carter, H.Ballentine, Mamawala, Mufaddal M.

Journal:

Danil V. Makarov, Cameron Marlow, Jonathan I. Epstein, M. Craig Miller, Patricia Landis, Alan W. Partin, H. Ballentine Carter, Robert W. Veltri

Année:

2020

Langue:

english

Fichier:

PDF, 844 KB

english, 2020

Using nuclear morphometry to predict the need for treatment among men with low grade, low stage prostate cancer enrolled in a program of expectant management with curative intent

Journal:

Dr. H. Ballentine Carter, Donald S. Coffey

Année:

2008

Langue:

english

Fichier:

PDF, 147 KB

english, 2008

The prostate: An increasing medical problem

Journal:

Dr H. Ballentine Carter, Jay D. Pearson, E. Jeffrey Metter, Daniel W. Chan, Reubin Andres, James L. Fozard, William Rosner, Patrick C. Walsh

Année:

1990

Langue:

english

Fichier:

PDF, 550 KB

english, 1990

Longitudinal evaluation of serum androgen levels in men with and without prostate cancer

Journal:

Jay D. Pearson, Christopher H. Morrell, Patricia K. Landis, H. Ballentine Carter, Larry J. Brant

Année:

1995

Langue:

english

Fichier:

PDF, 527 KB

english, 1995

Mixed-effects regression models for studying the natural history of prostate disease

Journal:

Statistics in Medicine

Année:

1994

Langue:

english

Fichier:

PDF, 842 KB

english, 1994

Nonpalpable prostate cancer detected in the prostate-specific antigen era

H. Ballentine Carter, Jonathan I. Epstein

Journal:

World Journal of Urology

Année:

1997

Langue:

english

Fichier:

PDF, 134 KB

english, 1997

Prediction of significant cancer in men with stage Tic adenocarcinoma of the prostate

Journal:

World Journal of Urology

Année:

1997

Langue:

english

Fichier:

PDF, 534 KB

english, 1997

Why do cells metastasize?

H. Ballentine Carter, John T. Isaacs

Journal:

World Journal of Urology

Année:

1990

Langue:

english

Fichier:

PDF, 452 KB

english, 1990

The role of prostate-specific antigen velocity in prostate cancer early detection

Steven R. Potter, H. Ballentine Carter

Journal:

Current Urology Reports

Année:

2000

Langue:

english

Fichier:

PDF, 232 KB

english, 2000

Screening for prostate cancer by using random-effects models

Larry J. Brant, Shan L. Sheng, Christopher H. Morrell, Geert N. Verbeke, Emmanuel Lesaffre, H. Ballentine Carter

Journal:

Journal of the Royal Statistical Society: Series A (Statistics in Society)

Année:

2003

Langue:

english

Fichier:

PDF, 165 KB

english, 2003

DNA content in the diagnostic biopsy for benign-adjacent and cancer-tissue areas predicts the need for treatment in men with T1c prostate cancer undergoing surveillance in an expectant management programme

Sumit Isharwal, Danil V. Makarov, H. Ballentine Carter, Jonathan I. Epstein, Alan W. Partin, Patricia Landis, Cameron Marlow, Robert W. Veltri

Journal:

Phillip M. Pierorazio, Luigi Ferrucci, Anna Kettermann, Dan L. Longo, E. Jeffrey Metter, H. Ballentine Carter

Année:

2010

Langue:

english

Fichier:

PDF, 197 KB

english, 2010

Serum testosterone is associated with aggressive prostate cancer in older men: results from the Baltimore Longitudinal Study of Aging

Journal:

Stacy Loeb, H. Ballentine Carter, Edward M. Schaeffer, Shari M. Ling, Anna Kettermann, Luigi Ferrucci, E. Jeffrey Metter

Année:

2010

Langue:

english

Fichier:

PDF, 261 KB

english, 2010

Bone mineral content and prostate cancer risk: data from the Baltimore Longitudinal Study of Aging

Journal:

Anna E. Kettermann, Luigi Ferrucci, Bruce J. Trock, E. Jeffrey Metter, Stacy Loeb, H. Ballentine Carter

Année:

2010

Langue:

english

Fichier:

PDF, 244 KB

english, 2010

Interpretation of the prostate-specific antigen history in assessing life-threatening prostate cancer

Journal:

Année:

2010

Langue:

english

Fichier:

PDF, 414 KB

english, 2010

Management of low (favourable)-risk prostate cancer

Journal:

Kenneth S. Tseng, Patricia Landis, Fadi Brimo, Alan W. Partin, Jonathan I. Epstein, H. Ballentine Carter

Année:

2011

Langue:

english

Fichier:

PDF, 551 KB

english, 2011

Repeat prostate biopsies predict location of index cancer in an active surveillance cohort

Journal:

Joan S. Ko, Patricia Landis, H. Ballentine Carter, Alan W. Partin

Année:

2011

Langue:

english

Fichier:

PDF, 240 KB

english, 2011

Effect of intra-observer variation in prostate volume measurement on prostate-specific antigen density calculations among prostate cancer active surveillance participants

Journal:

Alan W. Partin, Steven Piantadosi, Eric N. P. Subong, Cynthia A. Kelly, Steven Hortopan, Daniel W. Chan, Robert L. Wolfert, Harry G. Rittenhouse, H. Ballentine Carter

Année:

2011

Langue:

english

Fichier:

PDF, 258 KB

english, 2011

Clearance rate of serum-free and total PSA following radical retropubic prostatectomy

Journal:

Fritz H. Schröder, H. Ballentine Carter, Tineke Wolters, Roderick C.N. van den Bergh, Claartje Gosselaar, Chris H. Bangma, Monique J. Roobol

Année:

1996

Langue:

english

Fichier:

PDF, 401 KB

english, 1996

Primary care providers' perspectives on discontinuing prostate cancer screening

Craig E. Pollack, Elizabeth A. Platz, Nrupen A. Bhavsar, Gary Noronha, Gene E. Green, Sean Chen, H. Ballentine Carter

Journal:

Cancer

Année:

2012

Langue:

english

Fichier:

PDF, 797 KB

english, 2012

Early Detection of Prostate Cancer in 2007: Part 1: PSA and PSA Kinetics

Journal:

Stacy Loeb, Anna Kettermann, Luigi Ferrucci, Patricia Landis, E. Jeffrey Metter, H. Ballentine Carter

Année:

2008

Langue:

english

Fichier:

PDF, 283 KB

english, 2008

Rebuttal from Authors re: Axel Heidenreich. Identification of High-Risk Prostate Cancer: Role of Prostate-Specific Antigen, PSA Doubling Time and PSA Velocity. Eur Urol 2008;54:976–7

Journal:

Stacy Loeb, Anna Kettermann, Luigi Ferrucci, Patricia Landis, E. Jeffrey Metter, H. Ballentine Carter

Année:

2008

Langue:

english

Fichier:

PDF, 53 KB

english, 2008

PSA Doubling Time Versus PSA Velocity to Predict High-Risk Prostate Cancer: Data from the Baltimore Longitudinal Study of Aging

Journal:

Stacy Loeb, H. Ballentine Carter

Année:

2008

Langue:

english

Fichier:

PDF, 458 KB

english, 2008

Re: Long-Term Prediction of Prostate Cancer: Prostate-Specific Antigen (PSA) Velocity Is Predictive but Does Not Improve the Predictive Accuracy of a Single PSA Measurement 15 Years or More Before Cancer Diagnosis in a Large, Representative, Unscreened Population

Journal:

Patrick J. Bastian, Ballentine H. Carter, Anders Bjartell, Michael Seitz, Peter Stanislaus, Francesco Montorsi, Christian G. Stief, Fritz Schröder

Année:

2009

Langue:

english

Fichier:

PDF, 100 KB

english, 2009

Insignificant Prostate Cancer and Active Surveillance: From Definition to Clinical Implications

Journal:

Stacy Loeb, H. Ballentine Carter, William J. Catalona, Judd W. Moul, Fritz H. Schroder

Année:

2009

Langue:

english

Fichier:

PDF, 193 KB

english, 2009

Baseline Prostate-Specific Antigen Testing at a Young Age

Journal:

Stacy Loeb, H. Ballentine Carter, William J. Catalona, Judd Moul, Fritz H. Schroder

Année:

2012

Langue:

english

Fichier:

PDF, 175 KB

english, 2012

Reply from Authors re: Seth A. Strope, Gerald L. Andriole. Prostate-Specific Antigen–Based Risk Assessment in Younger Men. Eur Urol 2012;61:8–9

Journal:

Sonja I. Berndt, H. Ballentine Carter, Patricia K. Landis, Judith Hallfrisch, Sabine Rohrmann, E. Jeffrey Metter, Elizabeth A. Platz

Année:

2012

Langue:

english

Fichier:

PDF, 62 KB

english, 2012

Prediagnostic plasma vitamin C levels and the subsequent risk of prostate cancer

Journal:

Nutrition

Année:

2005

Langue:

english

Fichier:

PDF, 82 KB

english, 2005

Management of low (favourable)-risk prostate cancer

Journal:

John H. Nichols, Stacy Loeb, E. Jeffrey Metter, Luigi Ferrucci, H. Ballentine Carter

Année:

2012

Langue:

english

Fichier:

PDF, 359 KB

english, 2012

The relationship between prostate volume and prostate-specific antigen variability: data from the Baltimore Longitudinal Study of Aging and the Johns Hopkins Active Surveillance Program

Journal:

Ashley E. Ross, Zhaoyong Feng, Phillip M. Pierorazio, Patricia Landis, Patrick C. Walsh, H. Ballentine Carter, Bruce J. Trock, Edward M. Schaeffer

Année:

2012

Langue:

english

Fichier:

PDF, 225 KB

english, 2012

Effect of treatment with 5-α reductase inhibitors on progression in monitored men with favourable-risk prostate cancer

Journal:

Année:

2012

Langue:

english

Fichier:

PDF, 192 KB

english, 2012

PROSTATE-SPECIFIC ANTIGEN VELOCITY (PSAV) RISK COUNT IMPROVES THE SPECIFICITY OF SCREENING FOR CLINICALLY SIGNIFICANT PROSTATE CANCER

Journal:

J.Slade Hubbard, Sabine Rohrmann, Patricia K Landis, E.Jeffrey Metter, Denis C Muller, Reubin Andres, H.Ballentine Carter, Elizabeth A Platz

Année:

2012

Langue:

english

Fichier:

PDF, 106 KB

english, 2012

Association of prostate cancer risk with insulin, glucose, and anthropometry in the baltimore longitudinal study of aging

Journal:

Année:

2004

Langue:

english

Fichier:

PDF, 122 KB

english, 2004

Editorial comment

H.Ballentine Carter

Journal:

Année:

2004

Langue:

english

Fichier:

PDF, 57 KB

english, 2004

Continued undertreatment of older men with localized prostate cancer

H.Ballentine Carter

Journal:

Stephen J. Freedland, Michael C. Haffner, Patricia K. Landis, Christopher S. Saigal, H. Ballentine Carter

Année:

2004

Langue:

english

Fichier:

PDF, 53 KB

english, 2004

Obesity does not adversely affect health-related quality-of-life outcomes after anatomic retropubic radical prostatectomy

Journal:

Michael C. Haffner, Patricia K. Landis, Christopher S. Saigal, H. Ballentine Carter, Stephen J. Freedland

Année:

2005

Langue:

english

Fichier:

PDF, 111 KB

english, 2005

Health-related quality-of-life outcomes after anatomic retropubic radical prostatectomy in the phosphodiesterase type 5 ERA: Impact of neurovascular bundle preservation

Journal:

Jonathan I. Epstein, Harriete Sanderson, H. Ballentine Carter, Daniel O. Scharfstein

Année:

2005

Langue:

english

Fichier:

PDF, 114 KB

english, 2005

Utility of saturation biopsy to predict insignificant cancer at radical prostatectomy

Journal:

Kevin S. Ross, Harry A. Guess, H. Ballentine Carter

Année:

2005

Langue:

english

Fichier:

PDF, 121 KB

english, 2005

Estimation of treatment benefits when PSA screening for prostate cancer is discontinued at different ages

Journal:

Jeffrey M. Richman, H. Ballentine Carter, Marie N. Hanna, Jamie D. Murphy, Andrew J. Rowlingson, Robert A.F. Andrews, Christopher L. Wu

Année:

2005

Langue:

english

Fichier:

PDF, 125 KB

english, 2005

Efficacy of periprostatic local anesthetic for prostate biopsy analgesia: A meta-analysis

Journal: